Match Document Document Title
7485776 Disease resistance factors  
This invention relates to an isolated nucleic acid fragment encoding a disease resistance factor. The invention also relates to the construction of a chimeric gene encoding all or a substantial...
7485439 Nucleic acids encoding plasminogen fragments and methods of use  
Nucleic acid sequence encoding kringle region fragment of plasminogen vectors comprising such nucleic acid, and methods of use of such nucleic acids, Ribonucleic and deoxyribonucleic acid sequence...
7485456 Modulators of TNF receptor associated factor (TRAF), their preparation and use  
A DNA sequence encoding a protein capable of binding to a tumor necrosis factor receptor-associated factor (TRAF) molecule, TRAF-binding proteins, their isoforms, analogs, fragments and derivatives...
7485700 Interferon-like protein ZCYTO21  
The present invention relates to polynucleotide and polypeptide molecules for Zcyto21, an interferon-like protein, which is most closely related to interferon-α at the amino acid sequence level....
7485308 26199, 33530, 33949, 47148, 50226, 58764, 62113, 32144, 32235, 23565, 13305, 14911, 86216, 25206, and 8843 molecules and uses therefor  
The invention provides isolated nucleic acids molecules, designated 26199, 33530, 33949, 47148, 50226, 58764, 62113, 32144, 32235, 23565, 13305, 14911, 86216, 25206 and 8843 nucleic acid molecules....
7481994 Calcium biosensor polypeptides and methods of use  
The invention features methods and compositions for determining states of intracellular calcium stores in a eukaryotic cell. Also provided are methods for identifying an agent (e.g., a gene product...
7482141 Methods and compositions for vitamin K epoxide reductase  
The present invention provides a method of identifying a human subject having increased or decreased sensitivity to warfarin, comprising detecting in the subject the presence of a single nucleotide...
7482138 PAK5-related compositions and methods  
This invention provides nucleic acids encoding human PAK5-related proteins, and provides the encoded proteins. This invention also provides vectors, cells and compositions. Finally, this invention...
7482147 Ubiquitin protease  
The invention provides isolated nucleic acids molecules and proteins, designated 27411, 23413, 22438, 23553, 25278, 26212, NARC SC1, NARC 10A, NARC 1, NARC 12, NARC 13, NARC17, NARC 25, NARC 3,...
7482432 AXMI-003, a delta-endotoxin gene and methods for its use  
Compositions and methods for conferring pesticidal activity to bacteria, plants, plant cells, tissues and seeds are provided. Compositions comprising a coding sequence for a delta-endotoxin...
7482139 Variants of antithrombin III  
Disclosed are compositions and methods related to variant antithrombin III molecules.
7482008 Human T cell reactive feline protein (TRFP) isolated from house dust and uses therefor  
A substantially pure, covalently linked human T cell reactive feline protein (TRFP) has been isolated from vacuum bag extract obtained by affinity purification of house dust collected from several...
7482017 Flavivirus variants having phenotypic variation and immunogenic compositions thereof  
The present invention concerns isolated attenuated flaviviruses , such as West Nile viruses, having modifications that provide phenotypic varation, particularly in comparison to a more virulent...
7482440 Hemopoietin receptor protein, NR10  
The inventors succeeded in isolating a novel hemopoietin receptor gene (NR10) using a sequence predicted from the extracted motif conserved in the amino acid sequences of known hemopoietin...
7482148 Recombinant calf-chymosin and a process for producing the same  
The present invention relates to a recombinant calf-Chymosin protein as set forth in SEQ ID No. 1; a recombinant calf-Chymosin gene as set forth in SEQ ID No. 2 encoding the protein comprising...
7482140 L-tyrosine-producing bacterium and a method for producing L-tyrosine  
The present invention describes the production of L-tyrosine by culturing in a medium an Escherichia bacterium which has L-tyrosine-producing ability and which carries a mutant prephenate...
7482015 Optimized expression of HPV 45 L1 in yeast  
Synthetic DNA molecules encoding the HPV45 L1 protein are provided. Specifically, the present invention provides polynucleotides encoding HPV45 L1 protein, wherein said polynucleotides have been...
7479382 Nematode fatty acid desaturase-like sequences  
Nucleic acid molecules from nematodes encoding fatty acid desaturase polypeptides are described. Fatty acid desaturase-like polypeptide sequences are also provided, as are vectors, host cells, and...
7479383 Modified pyrroloquinoline quinone (PQQ) dependent glucose dehydrogenase excellent in substrate specificity  
PQQGDH having an improved substrate specificity or having an improved specific activity in an assay system using ferricyanide ion as a mediator is provided. Modified PQQGDH having the enhanced...
7479389 ARG1, ARG2, ARG3, HIS1, HIS2, HIS5, HIS6 genes and methods for stable genetic integration  
Novel genes encoding P. pastoris ARG1, ARG2, ARG3, HIS1, HIS2, HIS5 and HIS6 are disclosed. A method for inactivating alternately at least two biosynthetic pathways in a methylotrophic yeast is...
7479387 Compositions and methods for the synthesis and subsequent modification of uridine-5′-diphosphosulfoquinovose (UDP-SQ)  
The present invention is directed to compositions and methods related to the synthesis and modification of uridine-5′-diphospho-sulfoquinovose (UDP-SQ). In particular, the methods of the present...
7479281 Botulinum toxin for treating postherpetic neuralgia  
Methods for treating conditions in an animal or human subject. The conditions may be pain, skeletal muscle conditions, smooth muscle conditions, glandular conditions and cosmetic conditions. The...
7479373 Method for identifying compounds modulating taste transduction  
The invention provides isolated nucleic acid and amino acid sequences of taste cell specific G-protein coupled receptors, antibodies to such receptors, methods of detecting such nucleic acids and...
7479379 Methods for altering protein production rates  
Methods for altering the cellular secretion rate of a protein, such as an antibody and the altered cells produced by the method are disclosed. The methods and altered cells are useful for producing...
7479278 Troponin I polypeptide fragments and uses thereof  
Polypeptides corresponding to stable, circulating degradation products of troponin I (TnI) are described. The fragments comprise a sequence of the N-terminus of native cardiac TnI with 95-115 amino...
7479280 Virus-like particles for the induction of autoantibodies  
The invention described herein relates to compositions and methods for stimulating immune responses in vivo against a tolerogen. Novel biotechnological tools, pharmaceuticals, therapeutics and...
7479384 Nematode MDH-like sequences  
Disclosed are two nucleic acid molecules from M. incognita encoding malate dehydrogenase-like (MDH-like) polypeptides. The MDH-like polypeptide sequences are also provided, as are vectors, host...
7479549 Recombinant canine thyroid stimulating hormone and methods of production and use thereof  
The invention includes a nucleic acid having a sequence at least 98% homologous to SEQ ID NO: 1, which encodes the α subunit of canine thyroid stimulating hormone (TSH). The invention also...
7479284 Babesia canis vaccine  
The present invention relates to nucleic acid sequences encoding novel Babesia canis associated proteins and to cDNA fragments, recombinant DNA molecules and live recombinant carriers comprising...
7476391 Anti-bacterial vaccine compositions  
Gram negative bacterial virulence genes are identified, thereby allowing the identification of novel anti-bacterial agents that target these virulence genes and their products, and the provision of...
7476527 UDP-galactose:β-N-acetyl-glucosamine β-1,3-galactosyl transferases, β-3Gal-T5  
A novel gene defining a novel enzyme in the UDP-D-galactose: β-N-acetylglucosamine / β-N-acetylgalactosamine β 1,3 galactosyltransferase family, termed β 3 Gal-T 5 , with unique enzymatic...
7476518 Nucleic acids encoding fluorescent proteins and methods of using the same  
A GFP with an F64L mutation and E222G mutation is provided. This GFP has a bigger Stokes shift compared to other GFPs making it very suitable for high throughput screening due to a better...
7476528 Proteins producing an altered immunogenic response and methods of making and using the same  
The present invention relates to novel protein variants that exhibit reduced allergenicity when compared to the parental proteins. Also included are DNA molecules that encode the novel variants,...
7476532 Mannitol induced promoter systems in bacterial host cells  
The present invention provides methods for producing recombinant peptides in a bacterial host utilizing a mannitol, arabitol, glucitol, or glycerol-inducible promoter, wherein the host bacterial...
7476731 Variants of the alpha 1 subunit of human AMPK  
Variants of the α subunit of AMPK, nucleic acids encoding such variants, and methods for their use are provided.
7476516 Methods for producing biological substances in pigment-deficient mutants of Bacillus cells  
The present invention relates to methods of producing a heterologous biological substance, comprising: (a) cultivating a mutant of a parent Bacillus cell under conditions conducive for the...
7476389 Papillomavirus vaccines  
A method of providing papilloma virus like particles which may be used for diagnostic purposes or for incorporation in a vaccine for use in related to infections caused by papilloma virus. The...
7476524 Canine COX-2 nucleic acid molecules  
The present invention relates to canine COX-1 and COX-2 proteins; to canine COX-1 and COX-2 nucleic acid molecules, including those that encode such COX-1 and COX-2 proteins, respectively; to...
7476777 Biological containment system  
The invention relates to materials and methods useful for controlling the unwanted spread of transgenic traits. The methods involve an apomictic plant containing a transgene for a desired trait and...
7476517 Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics  
The invention relates to virus like particles, their preparation and their use in pharmaceutical screening and functional genomics. The invention further provides a variety of assay formats to be...
7473820 Flax (Linum usitatissimum L.) seed-specific promoters  
The present invention is directed to promoters of flax conlinin and ω-3 desaturase genes. The promoters guide high levels of the expression exclusively in flax developing seeds. This specific...
7473770 Cynomolgus monkey dickkopf-4, nucleotides encoding same, and uses thereof  
The cynomolgus monkey Dickkopf-4 (cDkk-4) protein, isolated nucleic acid molecules which encode the cDkk-4 protein, and recombinant vectors and hosts comprising DNA encoding the cDkk-4 protein are...
7473537 Cloned glucagon-like peptide-2 receptors  
The invention relates to nucleotides and amino acid sequences encoding glucagon-like peptide 2 receptors, recombinant host cells transformed with such nucleotides, and methods of using the same in...
7473545 Enzymatic production of glycolic acid  
Various methods are provided for the enzymatic production of glycolic acid from glycolonitrile. These methods include: 1) use of Acidovorax facilis 72W nitrilase mutants having improved nitrilase...
7473538 ***WITHDRAWN PATENT AS PER THE LATEST USPTO WITHDRAWN LIST***
Sequence-determined DNA fragments encoding cytochrome P450 proteins
 
The present invention provides DNA molecules that constitute fragments of the genome of a plant, and polypeptides encoded thereby. The DNA molecules are useful for specifying a gene product in...
7473538 ***WITHDRAWN PATENT AS PER THE LATEST USPTO WITHDRAWN LIST***
Sequence-determined DNA fragments encoding cytochrome P450 proteins
 
The present invention provides DNA molecules that constitute fragments of the genome of a plant, and polypeptides encoded thereby. The DNA molecules are useful for specifying a gene product in...
7473536 Isolated avian cell that expresses Vaccinia virus host range genes  
The invention concerns an Avipoxvirus comprising in the viral genome a Vaccinia virus host range gene or a homologue of said host range gene. The invention further relates to cells, preferably...
7473679 Treatments employing neuronal exocytosis-inhibiting peptides  
The peptide has a sequence of 3 to 30 adjacent amino acids from the amino end of protein SNAP-25 and is useful as neuronal exocytosis inhibitor. The cosmetic and pharmaceutical compositions contain...
7473762 Proteins and polypeptides from coagulaslase-negative staphylococci  
Proteins and polypeptides from coagulase-negative staphylococcal bacteria such as S. epidermidis , including proteins designated SdrF, SdrG and SdrH, and their effective fragments such as their...
7473678 Platelet-derived growth factor compositions and methods of use thereof  
A method for promoting growth of bone, periodontium, ligament, or cartilage in a mammal by applying to the bone, periodontium, ligament, or cartilage a composition comprising platelet-derived...